ISSCR News
New Podcast Episode. PSC Developmental Bias: The Mechanism and the Variation in Human Neural Development
The guests on this episode of The Stem Cell Report studied functional variation in human PSC lines as they progress through neurectoderm versus mesendoderm lineages and fore- versus hind-brain development. They will discuss the origin and consequences of inter-individual variation in the early events orchestrating human neural development, the extent to which such variation might impact on adult health and disease, and how it might be exploited in stem cell therapy.
The Annual Meeting Program Highlights the Breadth of Global Talent
Developing the ISSCR Annual Meeting program has been both a privilege and a responsibility. Together with an incredible team of dedicated colleagues we have committed to highlight the entire breath of our field in partnership. The annual meeting is a time during which the ISSCR community comes together to be nourished by meaningful content and to learn from colleagues who may be at different stages of their careers, have different personal histories, come from different parts of the world, or come from different subfields of interest within the regenerative and stem cell field. Creating an Annual Meeting to make this possible involved recruiting program chairs and a program committee that complemented and expanded my view and embraced the process of working together as a team to reach our aspirations.
Member Spotlight: Kirsten Sadler (Edepli), PhD
I love learning, and I am intrinsically curious. By far the most rewarding part of the job is engaging in scientific discussions about data with my colleagues and members of my team.
Registration and Abstract Submission Now Open for the ISSCR 2025 Annual Meeting
Registration and abstract submission are open for the ISSCR 2025 Annual Meeting, where academic and industry innovators in stem cell science and regenerative medicine will gather for The Global Stem Cell Event 11-14 June in Hong Kong for the first time in the ISSCR’s history. The ISSCR extends its thanks to co-sponsors The University of Hong Kong, The Chinese University of Hong Kong, and The Hong Kong University of Science and Technology for their support of the meeting.
Ninth Circuit Reverses Lower Court, Reinforces FDA’s Authority to Regulate Unproven Stem Cell Products
In an important step to protect the public from unproven stem cell products, the U.S. Court of Appeals for the Ninth Circuit ruled in favor of the U.S. Food and Drug Administration in U.S. v. California Stem Cell Treatment Center, Inc., reversing the district court. The reversal fortifies FDA’s tiered, risk-based framework for the regulation of cell therapies and is consistent with a similar ruling in the Eleventh Circuit in 2021.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .